What You Should Know:
– A new report by Accenture, “Reinventing R&D in the Age of AI,” paints a clear picture: the biopharmaceutical industry stands at a critical juncture. Companies that embrace intelligent technologies like…
Continue Reading
What You Should Know:
– VenoStent, Inc., a medical device company pioneering a new approach to improve dialysis patient outcomes, announced the successful completion of its Series A funding round. The round closed at $20M,…
Continue Reading
Shahar Cohen, CTO at Verix
In a world full of options, companies need to compete on every prospect and existing customer. As the number of potential channels to reach customers increases, companies need to build…
Continue Reading
MedCity’s annual INVEST Digital Health conference, scheduled for September 18 in Dallas, will delve into innovation at the intersection of AI and drug development, investment trends, consumer-focused diagnostics and validating digital health tools.
This will…
Continue Reading
What You Should Know:
– The pharmaceutical and life sciences (PLS) sector is experiencing a resurgence in dealmaking activity, with a 20% increase in deal volume over the past year reported, according to PwC’s latest…
Continue Reading
What You Should Know:
– Sanofi, a global healthcare leader, and Biovac, a prominent South African biopharmaceutical company, announced a landmark partnership. This collaboration aims to establish local manufacturing of inactivated polio vaccines (IPV) in…
Continue Reading
What You Should Know:
– Aranscia, a leader in personalized diagnostics, and Signature RX, a prominent pharmacy supplier, announced a collaborative effort to improve the effectiveness of GLP-1 medications.
– The multi-phase partnership focuses on developing…
Continue Reading
What You Should Know:
– Boston Scientific Corporation (NYSE: BSX) announced a definitive agreement to acquire Silk Road Medical, Inc. (Nasdaq: SILK) for approximately $1.16 billion ($27.50 per share). Silk Road Medical is a leading…
Continue Reading
What You Should Know:
– Vultr, the world’s largest, privately-held cloud computing platform, today announced that Athos Therapeutics, Inc. (“Athos”), a clinical-stage biotechnology company, has chosen Vultr Cloud GPU to run its AI model training,…
Continue Reading
What You Should Know:
– Mika Health, a leading developer of digital therapeutics for cancer patients, announced a collaborative initiative called “UNITE” alongside pharmaceutical giants AstraZeneca and Daiichi Sankyo.
– The strategic initiative signifies a commitment…
Continue Reading
